natgillin/translations-raw huggingface dataset:
Since this <vaccine> <immunological veterinary medicinal product> has been prepared with live, attenuated microorganisms, appropriate measures should be taken to prevent contamination of the handler and other people that collaborate in the process.>
Ker je bilo <cepivo> <imunološko zdravilo> izdelano iz živih oslabljenih mikroorganizmov, so potrebni ustrezni ukrepi, da bi preprečili okužbo osebe, ki pride v stik s cepivom ter drugih oseb, ki sodelujejo pri cepljenju.>
<The <vaccine><immunological veterinary medicinal product> can be pathogenic for humans.
<Cepivo> <imunološko zdravilo> je za človeka lahko patogeno.
<5.1 Pharmacodynamic properties> <5.2 Pharmacokinetic particulars> <Environmental properties>
<5.1 Farmakodinamične lastnosti> <5.2 Farmakokinetični podatki>
Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
<Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) (http://www.ema.europa.eu/.
<Not applicable.> <In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.> <Do not mix with any other veterinary medicinal product<, except <diluentsolvent or other component> <recommended><supplied> <for use with the veterinary medicinal product>.>
<Ni smiselno.> <Zaradi pomanjkanja študij kompatibilnosti tega zdravila ne smemo mešati z drugimi zdravili za uporabo v veterinarski medicini.> <Ne mešajte z nobenim drugim zdravilom za uporabo v veterinarski medicini <, razen z vehikloms topilom ali drugo komponento> <, ki je priporočena> <, ki je priložena> < za uporabo s tem <zdravilom><cepivom>>.>
Personnel involved in attending vaccinated {species} should follow general hygiene principles (changing clothes, wearing gloves, cleaning and disinfection of boots) and take particular care in handling animal waste and bedding materials litter from recently vaccinated {species}.>
Osebje, ki oskrbujejo cepljene {živalske vrste} morajo upoštevati splošna higienska načela (menjava obleke, uporaba rokavic, čiščenje in razkuževanje čevljev) in morajo še posebej paziti pri ravnanju s steljoz iztrebkiizločki in steljonastiljem {živalskih vrst}, ki so bile pred kratkim cepljene.> <Namenjeno uporabniku:
<This veterinary medicinal product does not require any special temperature storage conditions.>*****
<Za shranjevanje zdravila ni posebnih temperaturnih omejitev.>*****
If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Če opazite kakršne koli resne stranske učinke, tudi tiste, ki niso navedeni v tem navodilu za uporabo ali mislite, da zdravilo ni delovalo, druge učinke, ki niso omenjeni v teh navodilih za uporabo,
CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
<POGOJI ALI OMEJITVE V ZVEZI Z VARNO IN UČINKOVITO UPORABO
<Not applicable.> <Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.>
<Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisizahtevami.>
<EXP {month/year}> <Once <broached><opened><diluted><reconstituted> <use by…> <use within…> <use immediately>.>
<EXP {mesec/leto}> < <Načeto> <odprto> <razredčeno> <rekonstituirano> zdravilo uporabite do…> <uporabite v…> <uporabite takoj>.>
Name and address of the manufacturer
 responsible for batch release {Name and address} <The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.>
Ime in naslov izdelovalcaproizvajalca (izdelovalcevproizvajalcev) zdravila, odgovornega (odgovornih) za sproščanjestitev serije {Ime in naslov} <V natisnjenem navodilu za uporabo zdravila mora biti navedeno ime in naslov izdelovalcaproizvajalca, odgovornega za sproščanje zadevne serije.>
<Date of first authorisation:> <{DD/MM/YYYY}><{DD month YYYY}.> <Date of last renewal:> <{DD/MM/YYYY}> <{DD month YYYY}.>
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET <{DD/MM/LLLL}> <{DD mesec LLLL}>… <Datum pridobitve dovoljenja za promet: > <{DD/MM/LLLL}> <{DD mesec LLLL}.> <Datum zadnjega podaljšanja dovoljenja za promet: > <{DD/MM/LLLL}> <{DD mesec LLLL}.>
<The <veterinary medicinal product><vaccine><immunological veterinary medicinal product> should be given at different sites.>
< To <zdravilo> <cepivo> < imunološko zdravilo> se daje na različna mesta.
<The manufacture, import, possession, sale, supply and/or use of {invented name} may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.
<Izdelava,uvoz/vnos, posedovanje, prodaja, oskrba in/ali uporaba zdravila {izmišljeno ime} je lahko v državi članici prepovedana na njenem celotnem ozemlju ali delu ozemlja v skladu z nacionalno zakonodajo.
<Lactation:> <Not applicable.>
<Laktacija:> <Ni smiselno.>
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
DATUM ZADNJE ODOBRITVE NAVODIL ZA UPORABO <Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) (http://www.ema.europa.eu/).>
<Special precautions for use in animals:> <Special precautions to be taken by the person administering the veterinary medicinal product to animals:> <Pregnancy:> <Lactation:> <Pregnancy and lactation:> <Lay:> <Fertility:> <Interaction with other medicinal products and other forms of interaction:> <Overdose (symptoms, emergency procedures, antidotes):> <Incompatibilities:>
POSEBNO(A) OPOZORILO(A) <Jih ni.> <Posebna opozorila za vsako ciljno živalsko vrsto: > <Posebni previdnostni ukrepi za uporabo pri živalih: > <Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo: > <Brejost: > <Laktacija: > <Brejost in laktacija: > <Nesnost: > <Plodnost::> <Medsebojno delovanje z drugimi zdravili in druge oblike interakcij: > <Preveliko odmerjanje (simptomi, nujni ukrepi, protistrupi): > <Inkompatibilnosti: >
<Manufacturer responsible for batch release:>
<ProizvajalecIzdelovalec, odgovoren za sproščanje serij:>
<The vaccine strain can be found in the environment for up to {x <days><weeks>}.
<Vakcinalni sev je možno najti v okolju v obdobju do {x <dni> <tednov>}.
A decision to use this <vaccine><immunological veterinary medicinal product> before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.>
Zato se za uporabo tega <cepiva> <imunološkega zdravila> pred ali po uporabi katerega koli drugega zdravila za uporabo v veterinarski medicini odločamo od primera od primera.
<OBLIGATION TO CONDUCT POST-AUTHORISATION MEASURES> <The MAH shall complete, within the stated timeframe, the following measures: Description
ZDRAVILA> <OBVEZNOST IZVEDBE UKREPOV PO PRIDOBITVI DOVOLJENJA ZA PROMET> <Imetnik dovoljenja za promet z zdravilom mora v spodaj navedenem časovnem okviru izvesti naslednje ukrepe: Opis
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
IME IN NASLOV IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER IMETNIKA DOVOLJENJA ZA IZDELAVOPROIZVAJALEC ZDRAVILA, ODGOVORENEGA ZA SPROŠČANJE SERIJ V EGP, ČE STA RAZLIČNA
<The periodic safety update report (PSUR) cycle should be restarted for submission of 6 monthly reports (covering all authorised presentations of the product) for the next two years, followed by yearly reports for the subsequent two years and thereafter at 3 yearly intervals.The data lock point (DLP) for the next PSUR would be {add DLP}.>[Only applicable, if justified after authorisation.]
<Posebne farmakovigilančne zahteve:> <Cikel rednih posodobljenih poročil o varnosti zdravila (PSUR) se ponovno začne z oddajo šestmesečnih poročil (vključene so vse odobrene oblike zdravila) v obdobju naslednjih dveh let, ki mu sledi oddaja dveh letnih poročil za naslednji dve leti, po tem obdobju pa se poročila oddajajo v triletnih obdobjih.
<This veterinary medicinal product does not require any special storage conditions.> <This veterinary medicinal product does not require any special temperature storage conditions.>*****
< Za shranjevanje zdravila niso potrebna posebnaih navodila.> <Za shranjevanje zdravila ni posebnih temperaturnih omejitev.>*****
<None.>
<Nič dni.>
<This veterinary medicinal product does not require any special storage conditions.>
< Za shranjevanje zdravila niso potrebna posebnaih navodila.
<Not applicable.>
<Ni smiselno.>
<Dispose of waste material in accordance with local requirements.> <Disposal: read package leaflet.>
<Odpadne stvari snovi odstranite v skladu z lokalnimi predpisizahtevami.
The Committee for Medicinal Products for Veterinary Use has recommended the inclusion of {name of the active substance(s)} in {name of the product} in table 1 (Allowed substances) of the annex to Commission Regulation (EU) No 37/2010 as follows:
<Odbor za zdravila za uporabo v veterinarski medicini je priporočil vključitev {< ime zdravilne učinkovine}> v {<ime zdravila}> v tabeloi 1 (dovoljene snovi) priloge Uredbe Komisije (EU) št.
<This being an approval under exceptional circumstances and pursuant to Article 39(7) of Regulation (EC) No 726/2004, the MAH shall conduct, within the stated timeframe, the following measures:
(7) Uredbe (ES) št. 726/2004, mora imetnik dovoljenja za promet v spodaj navedenem časovnem okviru izvesti naslednje ukrepe:
Any person intending to manufacture, import, possess, sell, supply and use <invented name> must consult the relevant Member State's competent authority on the current vaccination policies prior to the manufacture, import, possession, sale, supply and/or use.> <Any person intending to manufacture, import, possess, sell, supply and use this veterinary medicinal product must first consult the relevant Member State's competent authority on the current vaccination policies, as these activities may be prohibited in a Member State on the whole or part of its territory pursuant to national legislation.>
Vsakdo, ki namerava izdelovatiproizvajati, uvažati oziroma vnašati, posedovati, prodajati, oskrbovati in/ali uporabljati to zdravilo <izmišljeno ime>, se mora najprej posvetovati s pristojnim organom posamezne države članice o veljavnih programih cepljenja , saj so lahko te dejavnosti prepovedane v državi članici na njenem celotnem ozemlju ali delu ozemlja v skladu z nacionalno zakonodajoše pred izdelavo, uvozom oziroma vnosom, posedovanjem, prodajo, oskrbo in/ali uporabo.>
<The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals treated ) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).>
- zelo pogosti (neželeni učinki se pokažejo pri več kot 1 živali od 10 zdravljenih živali med enim ciklom zdravljenja) - pogosti (pri več kot 1, toda a manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda a manj kot 10 živali od 1.000 zdravljenih živali) - redki (pri več kot 1, toda a manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključnoujoč s posamezneimi primerie).>
<The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) during the course of one treatment) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).>
- zelo pogosti (neželeni učinki se pokažejo pri več kot 1 živali od 10 zdravljenih živali med enim ciklom zdravljenja) - pogosti (pri več kot 1, toda a manj kot 10 živali od 100 zdravljenih živali) - občasni (pri več kot 1, toda a manj kot 10 živali od 1.000 zdravljenih živali) - redki (pri več kot 1, todaa manj kot 10 živali od 10.000 zdravljenih živali) - zelo redki (pri manj kot 1 živali od 10.000 zdravljenih živali, vključujočno s posamezneimi primerei).>
Animal species MRLs Target tissues
MRL Ciljna tkiva
<Not applicable.> <Zero days.> <<Meat and offal><Eggs><Milk> <Honey>: {X} <days><hours>.> <{X} degree days.>
<<Meso in organi> <Mleko> <Jajca> <Med> : <{X} <ur> <dni>.> <{X} dnevnih stopinj}.>
<Consideration should be given to official guidance on the incorporation of medicated premixes in final feeds.>
<Upoštevati je treba uradna priporočila o dodajanju zdravilnih predmešanicpredmešanice za pripravo zdravilne krme mešanice v krmo.>
<Safety> <and> <efficacy> data are available which demonstrate that this <vaccine><immunological veterinary medicinal product> can be administered at least {X} <days><weeks> <before><after> the administration of {description of tested product(s).
< Podatki o varnosti <in> <učinkovitosti> so pokazali, da je to <cepivo> <imunološko zdravilo> varno dati vsaj {X} <dni> <tednov> <pred> <po> dajanju { opis testiranega(ih) proizvoda(ov)}.>
Do not use this veterinary medicinal product after the expiry date which is stated on the <label><carton><bottle><...> <after {abbreviation used for expiry date}>.
Tega Zzdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na <ovojnini > <zunanji ovojnini škatli> <steklenicički> <...> po {kratica, ki se uporablja za datum izteka roka uporabnosti}.> <Rok uporabnosti zdravila se nanaša na zadnji dan v navedenem mesecu.
<No information is available on the safety and efficacy of this <vaccine><immunological veterinary medicinal product> when used with any other veterinary medicinal product.
<Ni podatkov o varnosti ter učinkovitosti ob uporabi tega <cepiva> <imunološkega zdravila> s katerim koli drugim zdravilom za uporabo v veterinarski medicini.
<None.> <Do not use in ….> <Do not use in cases of hypersensitivity to the active substance(s)<, to the adjuvant(s)> or to any of the excipient(s).>
<Ne uporabite v primerihu preobčutljivosti na zdravilno(e) učinkovino(e) <, na dodatek(dodatke)> ali na katero koli pomožno snov.> 4.4.
During this time, the contact of immunosuppressed and unvaccinated {species} with vaccinated {species} should be avoided.>
V tem času se je treba izogibati stikom imunsko oslabljenih {živalskih vrst} in necepljenih {živalskih vrst} s cepljenimi {živalskimi vrstami}.> <Vakcinalni sev se lahko razširi na {živalske vrste}.
<The <vaccine><immunological veterinary medicinal product><veterinary medicinal product> should not be used if {description of the visible signs of deterioration}.>
}> 4.9 Odmerjanje in pot uporabe <Cepiva> <imunološkega zdravila> <zdravila> ne smemo uporabiti če {opis vidnih znakov propadanjakvarjenja }.>
<No information is available on the safety and efficacy of this <vaccine><immunological veterinary medicinal product> when used with any other veterinary medicinal product except the products mentioned above.
<Ni podatkov o varnosti ter učinkovitosti ob uporabi tega <cepiva> <imunološkega zdravila> s katerim koli drugim zdravilom za uporabo v veterinarski medicini razen z omenjenim.
<Not authorised for use in animals producing milk for human consumption.> <Do not use in pregnant animals which are intended to produce milk for human consumption within {X} months of expected parturition.> <Not authorised for use in birds producing eggs for human consumption, including replacement chicks which are intended to produce eggs for human consumption.> <Not for use in birds producing or intended to produce eggs for human consumption.>
<Ni dovoljena uporaba pri živalih, katerih mleko je namenjeno prehrani ljudi.> <Ne uporabite pri brejih živalih, katerih mleko je namenjeno prehrani ljudi, v obdobju {X} mesecev pred pričakovanim porodom.>
<Do not store above <25 °C><30 °C>.> <Store below <25 °C><30 °C>.> <Store in a refrigerator.> <Store and transport refrigerated.>* <Store in a freezer.> <Store and transport frozen.>** <Do not <refrigerate> <or> <freeze>.> <Protect from frost.>*** <Store in the original <container><package>.>
<Ne shranjujte pri temperaturi nad <25 °C> <30 °C>.> <Shranjujte pri temperaturi do pod <25 °C> <30 °C>.> <Shranjujte v hladilniku.> <Shranjujte in prevažajte v hladilniku.>* <Shranjujte v zamrzovalniku.> <Shranjujte in prevažajte zamrznjeno.>** <Ne <shranjujte <v hladilniku> <.> <ali> <zamrzujteovalniku>.> <Zaščitite pred zamrznitvijoZdravilo ne sme zmrzniti.>*** <Shranjujte v originalni(em) <vsebniku> <ovojnini>.>
<Batch><Lot> {number}
<Serija> <Lot>< >{številka}
<Protect from light.> <Store in a dry place.> <Protect from direct sunlight.>
<Zaščitite pred svetlobo.> <Shranjujte na suhem mestu.>
<Vaccinated {species} may excrete the vaccine strain up to {x <days> <weeks>} following vaccination.
<Cepljene {živalske vrste} lahko ta vakcinalni sev izločajo do {x <dni> <tedne(ov)>} po cepljenju.
<Do not use {name of product} if you notice {description of the visible signs of deterioration}.>
NASVET O PRAVILNI UPORABI ZDRAVILA <Ne uporabite {ime zdravila}, če opazite {opis vidnih znakov kvarjenja}.>
Marketing authorisation holder <and manufacturer responsible for batch release>:
<Imetnik dovoljenja za promet z zdravilom <in izdelovalec proizvajalec odgovoren za sproščanje serij>>:
<Vaccinated {species} may excrete the vaccine strain up to {x <days><weeks>} following vaccination.>
<Cepljene {živalske vrste} lahko ta vakcinalni sev izločajo do {x <dni> <tedne(ov)>} po cepljenju.>
<Safety> <and> <efficacy> data are available which demonstrate that this <vaccine><immunological veterinary medicinal product> can be administered on the same day but not mixed with {description of tested product(s).
< Podatki o <varnosti> <in> <učinkovitosti> so pokazali, da je to <cepivo> <imunološko zdravilo> varno dati na isti dan vendar ne zmešano z {opis testiranega(ih) proizvoda(ov)}.>
OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION>
DRUGI POGOJI IN ZAHTEVE KI JIH MORA IZPOLNITI IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM>
SPECIAL WARNING(S), IF NECESSARY <Read the package leaflet before use.> <Accidental injection is dangerous.> <<Accidental administration> <Contact with the mucosa> is dangerous.>
<Pred uporabo preberite navodilo za uporabo.> <Nenamerno injiciranje je nevarno.
<{MM/YYYY}> <{DD/MM/YYYY}> <{DD month YYYY}>
DATUM REVIZIJE BESEDILA <{MM/LLLL}> <{DD/MM/LLLL}> <{DD mesec LLLL}>{MM/LLLL}
Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.>
Potreben je strokoven, TAKOJŠEN, kirurški poseg ter morda tudi takojšnja incizija in izpiranje injiciranega mesta, zlasti če so prizadete tudi kite ali mehka tkiva prsta.> <Dolgoročni učinki tega zdravila na dinamiko populacije govnačev niso raziskani.
<Safety <and> <efficacy> data are available which demonstrate that this <vaccine><immunological veterinary medicinal product> can be mixed and administered with {description of tested product(s).
< Podatki o varnosti <in> < učinkovitosti> so pokazali, da se to <cepivo> <imunološko zdravilo> lahko meša in daje z {opis testiranega(ih) proizvoda(ov).
<Do not store above <25 °C><30 °C>.> <Store below <25 °C><30 °C>.> <Store in a refrigerator (2 °C - 8 °C).> <Store and transport refrigerated (2 °C - 8 °C).>* <Store in a freezer {temperature range}.> <Store and transport frozen {temperature range}.>** <Do not <refrigerate> <or> <freeze>.> <Protect from frost.>*** <Store in the original <container><package>.>
<Ne shranjujte pri temperaturi nad <25 °C> <30 °C>.> <Shranjujte pri temperaturi do pod <25 °C> <30 °C>.> <Shranjujte v hladilniku (2 °C - 8 °C).> <Shranjujte in prevažajte v hladilniku (2 °C - 8 °C)>.
For the full list of excipients, see section 6.1.
<Pomožne snovi (vključno z dodatki), navedene v poglavju 6.1.
<Not applicable.> <For use by veterinary surgeons only.>
<Ni smiselno.> < Zdravilo lahko daje samo veterinar .>
<Appropriate veterinary and husbandry measures should be taken to avoid spread of the vaccine strain to susceptible species.>
> Potrebni so posebni previdnostni ukrepi, da bi se izognili širjenju vakcinalnega seva na {živalske vrste}.>.
<The excipients, listed in section 6.1 of the SPC are <either> <allowed substances for which table 1 of the annex to Commission Regulation (EU) No 37/2010 indicates that no MRLs are required> <or> <considered as not falling within the scope of Regulation (EC) No 470/2009 when used as in this veterinary medicinal product>.>
<Za pPomožne snovi, navedene v poglavju 6.1 SPC , tabela 1 (dovoljene snovi)<so bodisi> < dovoljenje snovi, za katere tabela 1 priloge Uredbe Komisije (EU) št. 37/2010 določa, da MRL ni potreben> <ali pa,> <ne spadajo v področje uporabe Uredbe (ES) št. 470/2009, kadarkot so uporabljene tako kot v tem zdravilu za uporabo v veterinarski medicini, niso vključene v Uredbo(ES) št. 470/2009>.>
NAME OF THE VETERINARY MEDICINAL PRODUCT
IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM
<{Species} and unvaccinated {species} in contact with vaccinated {species} may react to the vaccine strain, presenting clinical signs such as ….>
<Potrebni so ustrezni veterinarski in živinorejski ukrepi, da bi preprečili širitev vakcinalnega seva na dovzetne živalske vrste.> <{Živalske vrste} in necepljene {živalske vrste} lahko v stiku s cepljenimi {živalskimi vrstami} reagirajo na vakcinalni sev in pri tem kažejo klinične znake kot npr…>
<Can be used during pregnancy.> <The use is not recommended (during the whole or part of the pregnancy).> <Do not use (during the whole or part of the pregnancy).> <The use is not recommended during <pregnancy><lactation>.> <Use only accordingly to the benefit-risk assessment by the responsible veterinarian.> <Laboratory studies in {species} have not produced any evidence of <teratogenic>, <foetotoxic>, <maternotoxic> effects.> <Laboratory studies in {species} have shown evidence of <teratogenic>, <foetotoxic>, <maternotoxic> effects.>
<Uporabite le v skladu z oceno razmerja korist-/tveganje odgovornega veterinarja.> < Z laboratorijskimi študijami {na živalskih vrstah} niso bili dokazani <teratogeni>, <fetotoksični>
STATEMENT OF THE MRLs <Not applicable.> [For pharmaceutical products] The active substance
 in {name of the product} <is><are> <an> allowed substance
 as described in table 1 of the annex to Commission Regulation (EU) No 37/2010: Pharmaco-logically active substance
NAVEDBA NAJVIŠJIH DOVOLJENIH KOLIČIN OSTANKOV ZDRAVILA (MRL) <Ni smiselno.> [For pharmaceutical products] <Zdravilna Uučinkovina> <Zdravilne uUčinkovine> v {<ime zdravila}><je dovoljena učinkovina><so dovoljene učinkovine>, kot <je navedena> <so navedene> v tabeli 1(dovoljene snovi)
<Shelf life after first opening the container: ….> <Shelf life after <dilution><reconstitution> according to directions: ….> <Shelf life after incorporation into meal or pelleted feed: ….>
<Rok uporabnosti po prvem odpiranju vsebnika: ….> <Rok uporabnosti po <razredčenju> <ali> <rekonstituciji> v skladu z navodili: ….
<The safety of the veterinary medicinal product has not been established during <pregnancy><lactation><lay>.>
Uporaba v obdobju brejosti, laktacije ali nesnosti <Varnost zdravila v obdobju <brejosti> <laktacije> <nesnosti > ni bila ugotovljena.